Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles

Estimating the Risk of Severe Peanut Allergy Using Clinical Background and IgE Sensitization Profiles

Background: It is not well-understood why symptom severity varies between patients with peanut allergy (PA).Objective: To gain insight into the clinical profile of subjects with mild-to-moderate and severe PA, and investigate individual and collective predictive accuracy of clinical background and I...

Full description

Bibliographic Details
Main Authors: Mareen R. Datema, Sarah A. Lyons, Montserrat Fernández-Rivas, Barbara Ballmer-Weber, André C. Knulst, Riccardo Asero, Laura Barreales, Simona Belohlavkova, Frédéric de Blay, Michael Clausen, Ruta Dubakiene, Cristina Fernández-Perez, Philipp Fritsche, David Gislason, Karin Hoffmann-Sommergruber, Monika Jedrzejczak-Czechowicz, Laurian Jongejan, Marek L. Kowalski, Tanya Z. Kralimarkova, Jonas Lidholm, Nikolaos G. Papadopoulos, Todor A. Popov, Nayade del Prado, Ashok Purohit, Isabel Reig, Suranjith L. Seneviratne, Athanassios Sinaniotis, Emilia Vassilopoulou, Serge A. Versteeg, Stefan Vieths, Paco M. J. Welsing, E. N. Clare Mills, Thuy-My Le, Aeilko H. Zwinderman, Ronald van Ree
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Allergy
Subjects:
EuroPrevall
iFAAM
peanut allergy
severity
prediction
clinical background
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2021.670789/full

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2021.670789/full

Similar Items